account_balance
Investment manager · 13F filer · SEC CIK 1637359
Omega Fund Management, LLC
Reported value$186Mas of Jun 30, 2026
Positions10 1 new, 1 sold out
Top 10 weight100.0%BCAX alone is 29%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
This fund reports 10 stocks.
BCAXBicara Therapeutics Inc.
29.1%Trimmed −24%
NUVBNuvation Bio Inc.
24.7%
KMTSKestra Med Technologies Ltd
14.0%
BBOTBridgeBio Oncology Therapeutics Inc.
13.5%
BBNXBeta Bionics Inc.
11.1%
ALMSAlumis Inc.
3.7%
SANA1.6%IMA1.4%enGene Holdings Inc.0.8%
BCAXBicara Therapeutics Inc.
29.1%Trimmed −24%
NUVBNuvation Bio Inc.
24.7%
KMTSKestra Med Technologies Ltd
14.0%
BBOTBridgeBio Oncology Therapeutics Inc.
13.5%
BBNXBeta Bionics Inc.
11.1%
ALMS3.7%SANABox size is the share of the fund. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 10 as a list
BCAX Bicara Therapeutics Inc. 29.1% Trimmed −24%NUVB Nuvation Bio Inc. 24.7% HeldKMTS Kestra Med Technologies Ltd 14.0% HeldBBOT BridgeBio Oncology Therapeutics Inc. 13.5% HeldBBNX Beta Bionics Inc. 11.1% HeldALMS Alumis Inc. 3.7% HeldSANA Sana Biotechnology, Inc. 1.6% HeldIMA ImageneBio, Inc. 1.4% Held
enGene Holdings Inc. 0.8% Held
ODTX Odyssey Therapeutics Inc. 0.0% NewWhat changed